{"passport":{"unfragile":{"@version":"1.0","version":"2026-05","artifact":{"id":"tool_aqemia","slug":"aqemia","name":"AQEMIA","type":"product","url":"https://www.aqemia.com","page_url":"https://unfragile.ai/aqemia","categories":["data-analysis"],"tags":[],"pricing":{"model":"paid","free":false,"starting_price":null},"status":"active","verified":false},"capabilities":[{"id":"tool_aqemia__cap_0","uri":"capability://drug.discovery.quantum.inspired.molecular.property.prediction","name":"quantum-inspired molecular property prediction","description":"Predicts molecular properties (solubility, stability, toxicity, etc.) using quantum-inspired machine learning algorithms. Provides rapid computational estimates of how molecules will behave without requiring full quantum mechanical simulations.","intents":["I need to quickly estimate if a molecule has desirable properties before synthesizing it","I want to reduce computational time for molecular property calculations from weeks to hours","I need to screen thousands of candidate molecules for basic feasibility"],"best_for":["computational chemists","drug discovery teams","medicinal chemists"],"limitations":["accuracy depends on training data coverage","may not capture edge cases in novel chemical scaffolds","requires standardized molecular input formats"],"requires":["molecular structure data (SMILES or 3D coordinates)","access to AQEMIA platform","basic understanding of molecular properties"],"input_types":["molecular structures (SMILES notation)","3D molecular coordinates","chemical structure files (SDF, MOL)"],"output_types":["numerical property predictions","confidence scores","property reports"],"categories":["drug-discovery","computational-chemistry","molecular-design"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_aqemia__cap_1","uri":"capability://drug.discovery.binding.affinity.prediction.for.protein.ligand.interactions","name":"binding affinity prediction for protein-ligand interactions","description":"Predicts how strongly a small molecule (ligand) will bind to a target protein using quantum-inspired AI models. Enables rapid ranking of compounds by predicted binding strength without expensive docking simulations.","intents":["I need to rank candidate compounds by their predicted binding strength to my drug target","I want to identify the most promising molecules before running expensive molecular docking studies","I need to accelerate lead optimization by predicting binding affinity changes from structural modifications"],"best_for":["structure-based drug designers","medicinal chemists","computational biologists"],"limitations":["predictions may not account for allosteric effects or protein dynamics","accuracy varies by protein family and ligand type","requires known target protein structure"],"requires":["target protein structure (PDB format or similar)","ligand molecular structures","training data for similar protein-ligand pairs"],"input_types":["protein structures (PDB files)","ligand structures (SMILES or 3D coordinates)","binding site information"],"output_types":["binding affinity scores (Kd/Ki predictions)","ranking lists","confidence intervals"],"categories":["drug-discovery","computational-chemistry","target-validation"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_aqemia__cap_2","uri":"capability://drug.discovery.molecular.design.optimization.for.drug.like.properties","name":"molecular design optimization for drug-like properties","description":"Suggests structural modifications to molecules to improve drug-like properties (ADMET: absorption, distribution, metabolism, excretion, toxicity) while maintaining or improving binding affinity. Guides medicinal chemists toward compounds more likely to succeed in development.","intents":["I have a lead compound with good binding but poor solubility—what structural changes should I make?","I need to optimize a molecule for better oral bioavailability while keeping target potency","I want to reduce predicted toxicity or off-target effects through rational design suggestions"],"best_for":["medicinal chemists","lead optimization teams","structure-activity relationship (SAR) analysts"],"limitations":["suggestions are computational predictions, not guaranteed to work in practice","may not account for synthetic accessibility","requires validation through wet-lab synthesis"],"requires":["starting molecule structure","target protein structure","desired property constraints","access to AQEMIA optimization engine"],"input_types":["molecular structures","property constraints (solubility targets, toxicity thresholds)","binding affinity targets"],"output_types":["suggested structural modifications","predicted property improvements","modified molecule structures (SMILES)"],"categories":["drug-discovery","lead-optimization","molecular-design"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_aqemia__cap_3","uri":"capability://drug.discovery.high.throughput.virtual.screening.of.compound.libraries","name":"high-throughput virtual screening of compound libraries","description":"Rapidly screens large chemical libraries (thousands to millions of compounds) against a drug target using quantum-inspired predictions. Ranks compounds by predicted binding affinity and drug-like properties to identify top candidates for synthesis.","intents":["I have a library of 100,000 compounds and need to identify the top 100 to synthesize","I want to screen our internal compound collection against a new target in days instead of months","I need to prioritize which compounds to make based on computational predictions before wet-lab work"],"best_for":["large pharmaceutical companies","biotech firms with extensive compound libraries","screening teams"],"limitations":["computational predictions must be validated experimentally","library quality and diversity affect results","requires standardized compound data"],"requires":["compound library (SMILES or structure files)","target protein structure","computational infrastructure","AQEMIA platform access"],"input_types":["large compound libraries (CSV, SDF, or database format)","target protein structure","screening criteria (binding affinity, ADMET thresholds)"],"output_types":["ranked compound lists","binding affinity predictions for all compounds","prioritized synthesis recommendations"],"categories":["drug-discovery","screening","lead-identification"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_aqemia__cap_4","uri":"capability://drug.discovery.off.target.binding.prediction.and.toxicity.assessment","name":"off-target binding prediction and toxicity assessment","description":"Predicts potential binding to unintended protein targets and estimates toxicity liabilities using quantum-inspired models. Helps identify safety risks early before expensive preclinical testing.","intents":["I need to assess whether my lead compound might bind to off-targets and cause side effects","I want to predict potential toxicity issues before investing in animal studies","I need to identify which structural features are driving predicted toxicity so I can modify them"],"best_for":["safety assessment teams","medicinal chemists","drug development programs"],"limitations":["predictions are computational estimates, not definitive safety assessments","may not capture all toxicity mechanisms","requires comprehensive off-target panel data"],"requires":["ligand structure","panel of potential off-target proteins","toxicity training data"],"input_types":["molecular structures (SMILES)","off-target protein structures","historical toxicity data"],"output_types":["off-target binding predictions","toxicity risk scores","structural liability alerts"],"categories":["drug-discovery","safety-assessment","toxicology"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_aqemia__cap_5","uri":"capability://drug.discovery.structure.activity.relationship.sar.analysis.and.pattern.discovery","name":"structure-activity relationship (sar) analysis and pattern discovery","description":"Analyzes relationships between molecular structure and biological activity across compound series. Identifies structural features that drive binding affinity, potency, or toxicity to guide future design decisions.","intents":["I need to understand which structural features in my compound series are most important for binding","I want to identify common patterns in successful compounds to guide new designs","I need to explain why certain structural modifications improved or worsened activity"],"best_for":["medicinal chemists","SAR analysts","lead optimization teams"],"limitations":["insights are data-dependent and may not generalize beyond the series","requires sufficient compound diversity for pattern recognition","human interpretation needed for actionable insights"],"requires":["compound series with measured biological activity","molecular structures","activity data (binding affinity, potency, etc.)"],"input_types":["compound structures (SMILES)","measured activity values (Kd, IC50, etc.)","chemical property data"],"output_types":["SAR reports","feature importance rankings","structural pattern visualizations","design recommendations"],"categories":["drug-discovery","data-analysis","lead-optimization"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_aqemia__cap_6","uri":"capability://drug.discovery.synthetic.accessibility.and.synthetic.route.prediction","name":"synthetic accessibility and synthetic route prediction","description":"Evaluates how difficult or easy it will be to synthesize predicted compounds and suggests synthetic routes. Helps prioritize compounds that are both computationally promising and synthetically feasible.","intents":["I have a list of predicted compounds but need to know which ones are actually synthesizable","I want to avoid designing molecules that require exotic or expensive synthetic chemistry","I need to estimate synthesis cost and timeline for prioritized compounds"],"best_for":["medicinal chemists","synthetic chemists","lead optimization teams"],"limitations":["synthetic accessibility is complex and context-dependent","predictions may not account for novel chemistry","requires validation by experienced synthetic chemists"],"requires":["molecular structures","access to synthetic chemistry knowledge base","cost/availability data for starting materials"],"input_types":["molecular structures (SMILES)","synthetic constraints or preferences"],"output_types":["synthetic accessibility scores","suggested synthetic routes","estimated synthesis difficulty/cost"],"categories":["drug-discovery","synthetic-chemistry","lead-optimization"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_aqemia__cap_7","uri":"capability://drug.discovery.multi.objective.molecular.optimization","name":"multi-objective molecular optimization","description":"Simultaneously optimizes multiple molecular properties (binding affinity, solubility, toxicity, synthetic accessibility) to find compounds that balance competing design goals. Enables trade-off analysis between different objectives.","intents":["I need a compound with good binding affinity AND good solubility—how do I balance these?","I want to find the Pareto frontier of compounds that optimize multiple properties simultaneously","I need to explore trade-offs between potency, safety, and synthesizability"],"best_for":["lead optimization teams","medicinal chemists","drug development programs"],"limitations":["balancing multiple objectives may require experimental validation","computational predictions have inherent uncertainty","user must define relative importance of objectives"],"requires":["molecular structures","multiple property prediction models","defined optimization objectives and weights"],"input_types":["molecular structures","property constraints and weights","optimization parameters"],"output_types":["optimized compound structures","Pareto frontier visualizations","trade-off analysis reports"],"categories":["drug-discovery","lead-optimization","molecular-design"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_aqemia__cap_8","uri":"capability://drug.discovery.quantum.inspired.molecular.similarity.and.clustering","name":"quantum-inspired molecular similarity and clustering","description":"Groups molecules by quantum-inspired similarity metrics to identify structurally related compounds with similar properties. Enables chemical space exploration and diversity assessment of compound libraries.","intents":["I need to understand the chemical diversity of my compound library","I want to find structurally similar compounds to a lead molecule for comparison","I need to cluster compounds by predicted properties to identify chemical series"],"best_for":["library curators","medicinal chemists","screening teams"],"limitations":["similarity metrics may not capture all relevant chemical properties","clustering results depend on chosen parameters","requires sufficient compound data for meaningful analysis"],"requires":["molecular structures","similarity metric definition","clustering parameters"],"input_types":["molecular structures (SMILES or 3D coordinates)","similarity thresholds"],"output_types":["similarity matrices","cluster assignments","chemical space visualizations"],"categories":["drug-discovery","data-analysis","library-management"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_aqemia__cap_9","uri":"capability://drug.discovery.integration.with.existing.drug.discovery.workflows.and.data.systems","name":"integration with existing drug discovery workflows and data systems","description":"Connects AQEMIA predictions to existing pharmaceutical informatics systems, ELNs (Electronic Lab Notebooks), and compound management databases. Enables seamless incorporation of AI predictions into established discovery processes.","intents":["I need to integrate AQEMIA predictions into our existing compound management system","I want to automatically feed AQEMIA results into our ELN for tracking and decision-making","I need to connect AQEMIA to our internal databases and workflows without disrupting current processes"],"best_for":["IT teams","informatics specialists","large pharmaceutical companies"],"limitations":["integration complexity depends on existing system architecture","requires significant IT resources and planning","may require custom development for specific workflows"],"requires":["existing informatics infrastructure","API access to AQEMIA","IT support and resources","data standardization"],"input_types":["compound data from existing systems","workflow specifications","data format requirements"],"output_types":["integrated predictions in existing systems","automated reports","workflow-compatible data formats"],"categories":["drug-discovery","informatics","integration"],"confidence":0.5,"matches":0,"success_rate":0}],"trust":{"score":44,"verified":false,"data_access_risk":"high","permissions":["molecular structure data (SMILES or 3D coordinates)","access to AQEMIA platform","basic understanding of molecular properties","target protein structure (PDB format or similar)","ligand molecular structures","training data for similar protein-ligand pairs","starting molecule structure","target protein structure","desired property constraints","access to AQEMIA optimization engine"],"failure_modes":["accuracy depends on training data coverage","may not capture edge cases in novel chemical scaffolds","requires standardized molecular input formats","predictions may not account for allosteric effects or protein dynamics","accuracy varies by protein family and ligand type","requires known target protein structure","suggestions are computational predictions, not guaranteed to work in practice","may not account for synthetic accessibility","requires validation through wet-lab synthesis","computational predictions must be validated experimentally","builder identity is not verified yet","no observed match outcomes yet"],"rank_breakdown":{"adoption":0.39999999999999997,"quality":0.82,"ecosystem":0.15000000000000002,"match_graph":0.25,"freshness":0.75,"weights":{"adoption":0.25,"quality":0.25,"ecosystem":0.1,"match_graph":0.35,"freshness":0.05}},"observed_outcomes":{"matches":0,"success_rate":0,"avg_confidence":0,"top_intents":[],"last_matched_at":null},"maintenance":{"status":"active","updated_at":"2026-05-24T12:16:29.133Z","last_scraped_at":"2026-04-05T13:23:42.550Z","last_commit":null},"community":{"stars":null,"forks":null,"weekly_downloads":null,"model_downloads":null,"model_likes":null}},"distribution":{"claim_url":"https://unfragile.ai/submit?claim=aqemia","compare_url":"https://unfragile.ai/compare?artifact=aqemia"}},"signature":"5WNSBELMhFlbK6jdkSz7UwcMSlRo2yUYysIAIfYvixSxQmdQ7d5rqFDlcdNYY6KUTj82NEA0DyujMo7DVuLPDQ==","signedAt":"2026-06-23T08:24:59.416Z","signedBy":"unfragile.ai","version":1},"_links":{"self":"https://unfragile.ai/api/v1/passport/aqemia","artifact":"https://unfragile.ai/aqemia","verify":"https://unfragile.ai/api/v1/verify?slug=aqemia","publicKey":"https://unfragile.ai/api/v1/trust-passport-public-key","spec":"https://unfragile.ai/trust","schema":"https://unfragile.ai/schema.json","docs":"https://unfragile.ai/docs"}}